본문 바로가기

Relation between the vasodilator-stimulated phosphoprotein phosphorylation assay and light transmittance aggregometry in East Asian patients after high-dose clopidogrel loading

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
AMERICAN HEART JOURNAL166(1) · pp.95 · 2013
피인용
Web of Science 14
JCR IF
JCR 2012 4.497
ISSN
0002-8703

저자

  1. 김인숙제1저자부산대학교, 암연구소, KO
  2. Jeong, Young-Hoon교신저자Sinai Ctr Thrombosis Res, Sch Med, Jinju 660702, KO
  3. Tantry, Udaya S.Sinai Ctr Thrombosis Res, US
  4. Park, Yongwhi경상대학교, Sch Med, Jinju 660702, KO
  5. Lee, Dong-Hyun경상대학교, Dept Lab Med, Jinju 660702, KO
  6. Bliden, Kevin P.Sinai Ctr Thrombosis Res, US
  7. Koh, Jin-Sin경상대학교, Sch Med, Jinju 660702, KO
  8. Park, Jeong Rang경상대학교, Sch Med, Jinju 660702, KO
  9. Jang, Jae-Sik인제대학교, Busan Paik Hosp, Coll Med, KO
  10. Hwang, Seok-Jae경상대학교, Sch Med, Jinju 660702, KO
  11. Koh, Eun-Ha경상대학교, Dept Lab Med, Jinju 660702, KO
  12. Kwak, Choong Hwan경상대학교, Sch Med, Jinju 660702, KO
  13. Hwang, Jin-Yong경상대학교, Sch Med, Jinju 660702, KO
  14. Kim, Sunjoo경상대학교, Dept Lab Med, Jinju 660702, KO
  15. Gurbel, Paul A.Sinai Ctr Thrombosis Res, US

초록

Objectives We analyzed the relation between platelet aggregation measured by light transmittance aggregometry (LTA) and platelet reactivity index (PRI) measured by vasodilator-stimulated phosphoprotein phosphorylation (VASP-P) assay. Background It has been suggested that LTA and VASP-P assay correlate differently according to the level of P2Y(12) receptor blockade by thienopyridines. Methods We simultaneously measured platelet function by LTA and VASP-P assay in 466 East Asians undergoing elective percutaneous coronary intervention after a 600-mg clopidogrel loading. High on-clopidogrel platelet reactivity (HPR) was defined by published consensus criteria. Results The degree of correlation between LTA and the VASP-P assay was different according to PRI levels. The correlation was lower in patients with poor responsiveness (PRI >60%) (n = 216) (0.035 <= r(2) <= 0.047), which was greater in responsive patients (PRI <= 60%) (n = 250) (0.315 <= r(2) <= 0.526). Despite a 600-mg loading, East Asians had a high prevalence of HPR (40.1%-63.5%), and the prevalence of HPR also differed between LTA and VASP-P assay. A PRI cutoff of >58% (area under curve, 0.829; 95% confidence intervals, 0.792-0.862; P < .001) corresponded to the published HPR cutoff by 5-mu M adenosine diphosphate-induced maximal platelet aggregation >46%. Conclusions This is the largest study correlating platelet reactivity measured by LTA and VASP-P assay in a percutaneous coronary intervention-treated cohort. The correlation is dependent on the level of responsiveness. Future investigations are needed to better define the optimal cutoffs of HPR measured by LTA and VASP-P assay for personalized antiplatelet therapy.

키워드

PERCUTANEOUS CORONARY INTERVENTIONTREATMENT PLATELET REACTIVITYVERIFYNOW P2Y12 ASSAYCARDIOVASCULAR EVENTSFUNCTION TESTSPROGNOSTIC-SIGNIFICANCEMYOCARDIAL-INFARCTIONADENOSINE-DIPHOSPHATEVASP PHOSPHORYLATIONSTENT IMPLANTATION

식별자

WoS UID
000321051400014